IRBESARTAN Tablets recalled over manufacturing violations
- Recall date
- November 2, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Golden State Medical Supply Inc. recalls IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90) Rx Only,…
- Recall number
- D-0264-2019
- FDA classification
- Class II
- Brand / firm
- Golden State Medical Supply Inc.
- Sold / distributed
- Product was distributed throughout the United States.
Why it was recalled
CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90) Rx Only, Manufactured by: SciGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Distributed by: GSMS, Incorporated, Camarillo, CA 93012, USA.
Get recall alerts
Free email alert whenever Golden State Medical Supply Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Golden State Medical Supply Inc.